Product cards show catalog-ready items for kit planning, batch review, and warehouse routing
Your GP may recommend checking TSH and free T4 levels approximately 36 months after starting Wegovy, then as clinically indicated
Additional non-oral contraception is advised for 4 weeks after starting treatment and for 4 weeks after each dose increase If pancreatitis is suspected (severe, persistent abdominal pain with or without vomiting), stop Mounjaro immediately and seek urgent medical assessment Mounjaro is not indicated for type 1 diabetes or diabetic ketoacidosis The medication is not recommended during pregnancy or breastfeeding Patients should report any suspected side effects via the MHRA Yellow Card Scheme
Data from real-world patient reports suggest that 60-70% of users experience complete nausea resolution by week 8-12 of therapy, regardless of final maintenance dose
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in peptide metabolic pathwaysincluding GIPR rs1800437, and FTO rs9939609 variantsthat may help provide context for how your body processes appetite-regulating hormones